title: Assessment of quality of life in Mexican patients suffering from chronic venous disorder - impact of oral Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid treatment - 'QUALITY Study'.
abstract: OBJECTIVE
  The present study assessed the effect of Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid (HMC-AA) on the quality of life (QoL) of patients suffering from chronic venous disorders (CVDs).
  
  
  METHODS
  An observational, multicentre and prospective study was performed with 917 Mexican patients suffering from CVD. Patients were treated with R. aculeatus-HMC-AA. After 12 weeks of treatment, the physicians then assessed the patients' symptoms and QoL using Short Form (SF-12) and Chronic Venous Insufficiency (CIVIQ) auto-questionnaires.
  
  
  RESULTS
  Patients were mainly women (86.7%), overweight or obese (72.7%) or C2 (39.3%)-C3 (27.6%). All symptoms and ankle circumferences significantly improved over time, with increasing clinical, aetiological, anatomical and pathophysiological (CEAP) classes and body mass index (BMI) (P < 0.001). Concerning QoL, all dimensions of the SF-12 score significantly improved over time (P < 0.001). Moreover, the CIVIQ scores significantly improved (P < 0.001) with increasing BMI (P < 0.002) and CEAP classes (P < 0.05).
  
  
  CONCLUSIONS
  R. aculeatus-HMC-AA significantly improved the symptoms and QoL of CVD patients.
authors.affiliation: Cabinet de Phlébologie, 32 Boulevard Dubouchage, 06000 Nice, France.
authors.forename: J J
authors.initials: JJ
authors.lastname: Guex
authors.forename: D M E
authors.initials: DM
authors.lastname: Enriquez Vega
authors.forename: L
authors.initials: L
authors.lastname: Avril
authors.forename: S
authors.initials: S
authors.lastname: Boussetta
authors.forename: C
authors.initials: C
authors.lastname: Taïeb
mesh_terms: D000284:Administration, Oral; D000328:Adult; D001205:Ascorbic Acid / Q000008:administration & dosage*; D015992:Body Mass Index; D002599:Chalcone / Q000008:administration & dosage*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005260:Female; D006569:Hesperidin / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008800:Mexico; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D010936:Plant Extracts / Q000008:administration & dosage; D011446:Prospective Studies; D011788:Quality of Life; D031443:Ruscus / Q000378:metabolism*; D011795:Surveys and Questionnaires; D014652:Vascular Diseases / Q000188:drug therapy* / Q000208:ethnology / Q000523:psychology*
chemical_list: D010936:Plant Extracts; D002599:Chalcone; D006569:Hesperidin; D001205:Ascorbic Acid